| 000 | 01785 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515210258.0 | ||
| 264 | 0 | _c20100414 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1471-6771 | ||
| 024 | 7 |
_a10.1093/bja/aeq019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAnnecke, T | |
| 245 | 0 | 0 |
_aSevoflurane preserves the endothelial glycocalyx against ischaemia-reperfusion injury. _h[electronic resource] |
| 260 |
_bBritish journal of anaesthesia _cApr 2010 |
||
| 300 |
_a414-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnesthetics, Inhalation _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCathepsin B _xmetabolism |
| 650 | 0 | 4 |
_aCoronary Circulation _xdrug effects |
| 650 | 0 | 4 |
_aCreatine Kinase _xmetabolism |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aGlycocalyx _xdrug effects |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 |
_aHistamine Release _xdrug effects |
| 650 | 0 | 4 |
_aIschemic Preconditioning, Myocardial _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMast Cells _xdrug effects |
| 650 | 0 | 4 |
_aMethyl Ethers _xpharmacology |
| 650 | 0 | 4 | _aMicroscopy, Electron |
| 650 | 0 | 4 |
_aMyocardial Reperfusion Injury _xmetabolism |
| 650 | 0 | 4 | _aOrgan Culture Techniques |
| 650 | 0 | 4 |
_aPeptide Hydrolases _xmetabolism |
| 650 | 0 | 4 | _aSevoflurane |
| 700 | 1 | _aChappell, D | |
| 700 | 1 | _aChen, C | |
| 700 | 1 | _aJacob, M | |
| 700 | 1 | _aWelsch, U | |
| 700 | 1 | _aSommerhoff, C P | |
| 700 | 1 | _aRehm, M | |
| 700 | 1 | _aConzen, P F | |
| 700 | 1 | _aBecker, B F | |
| 773 | 0 |
_tBritish journal of anaesthesia _gvol. 104 _gno. 4 _gp. 414-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/bja/aeq019 _zAvailable from publisher's website |
| 999 |
_c19542213 _d19542213 |
||